Metrics as of 10/17/2026, 08:51 AM (Berlin time), refresh in progress.
OrthoPediatrics Stock
OrthoPediatrics Corp.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- David R. Bailey
- Employees
- 602
- Market cap
- $573 M
- IPO
- 13/10/2017
OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and…
OrthoPediatrics stock: price history
1D
-2.7%
1W
+1.4%
1M
-5.2%
6M
+31.0%
YTD
+23.6%
1Y
+23.3%
2Y
-20.9%
5Y
-65.1%
10Y
–
Next earnings date
Next earnings date
27/10/2026 (in 10 days)
Volatility around earnings
~35% stronger price swings than usual
OrthoPediatrics stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Very robust business model with strong megatrend tailwind: wide moat, strong pricing power, predictable revenue.
OrthoPediatrics Corp. is a medical technology company focused on developing and distributing specialized implants and surgical systems globally for pediatric orthopedics. Its product portfolio encompasses solutions for trauma treatment, deformities, as well as offerings in spinal surgery and sports medicine. Through anatomical specialization in pediatric patients, the company delivers highly customized medical solutions. Revenue is generated through hardware sales, with trauma and deformity representing the largest segment. The business is geographically rooted primarily in the US market but is also expanding internationally.
- Revenue model
- Hardware sales
- Recurring revenue
- High
- Pricing power
- Moderate
- Moat
- Wide
- Moat type
- Network effects
- Capital intensity
- Medium
- Customer concentration
- Unknown
Ask the agents about OrthoPediatrics
Analyst assessment of OrthoPediatrics
PRICE TARGET LOW
US$22.00
CONSENSUS
US$25.25
MEDIAN
US$25.00
PRICE TARGET HIGH
US$29.00
0
STRONG BUY
12
BUY
1
HOLD
0
SELL
0
STRONG SELL
13
TOTAL · Buy
As of: 14/09/2026
OrthoPediatrics stock metrics
P/E
-13.07
P/B
1.52
EV/EBITDA
-142.57
RETURN ON EQUITY
-2.1%
NET MARGIN
-10.2%
DEBT/EQUITY
0.27
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
69.7%
FLOAT SHARES
18,195,397
AVG. DAILY VOLUME (30D)
189,759
Insider transactions (SEC)
Pritzker Jennifer N.
Squadron Capital LLC
Pelizzon David R
Squadron Capital LLC
Pritzker Jennifer N.
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -2.7%
Forums (Reddit)
Institutional holders
Comparable stocks
Frequently asked questions about OrthoPediatrics stock
What does OrthoPediatrics do?
OrthoPediatrics Corp. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is David R. Bailey, the company employs around 602 people.
The IPO was on 13/10/2017; the stock trades on NASDAQ under the ticker KIDS.
What do analysts say about OrthoPediatrics stock?
13 analysts rate the stock, the consensus is Buy (as of 14/09/2026).
The average price target is US$25.25, ranging from US$22.00 to US$29.00, with a median of US$25.00.
This is an external assessment, not a statement by Market Jury.
When does OrthoPediatrics report next?
The next earnings date is 27/10/2026.
Around past earnings, price swings were roughly 35% stronger than usual.
Does OrthoPediatrics pay a dividend?
No, OrthoPediatrics currently does not pay a dividend.
Which stocks are comparable to OrthoPediatrics?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get OrthoPediatrics stock analyzed?
Clicking "Analyze stock" lets five strategies assess OrthoPediatrics against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.